
How Impactful Would Cannabis Rescheduling Really Be?
As you likely have seen by now, a federal recommendation has been made to reclassify marijuana as a Schedule III drug from its current status

As you likely have seen by now, a federal recommendation has been made to reclassify marijuana as a Schedule III drug from its current status

The lack of clear cannabis regulation/acceptance at the federal level has again reared its ugly head causing further complications for both consumers and dispensaries –

State investigators have uncovered numerous instances of marijuana product adulteration by businesses attempting to manipulate contaminant testing. (Colorado MED) One of the fundamental incentives for

With the Governor of Minnesota signing off on cannabis legislation in late May, the state became the 23rd to legalize adult-use marijuana. But the continuing

The use and legality of cannabis continue to be contested issues, particularly when discussion turns to federal regulation – or the lack thereof. A recent

CBD and THC beverages make up 19% of the cannabis edibles market, yet most producers use glass or can packaging. To test the compatibility of

Across the U.S. and Canada, cannabis manufacturers and dispensaries are facing recalls and lawsuits due to mislabeling of THC, such as: Whether a cannabis label

Reminiscent of the childhood game of Captain, May I?, every small step the federal government takes forward on the path toward legalization of cannabis seems

We often write about the recall and regulatory implications of quality and safety when producing and retailing cannabis products, but there also are significant implications